1. Home
  2. PAI vs NBP Comparison

PAI vs NBP Comparison

Compare PAI & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Income Fund Inc.

PAI

Western Asset Investment Grade Income Fund Inc.

SELL

Current Price

$11.35

Market Cap

108.0M

Sector

Finance

ML Signal

SELL

NBP

NovaBridge Biosciences American Depositary Shares

HOLD

Current Price

$0.82

Market Cap

96.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAI
NBP
Founded
1973
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.0M
96.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PAI
NBP
Price
$11.35
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.67
AVG Volume (30 Days)
22.1K
★ 528.9K
Earning Date
01-01-0001
08-20-2026
Dividend Yield
★ 4.78%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.24
$0.77
52 Week High
$12.95
$5.19

Technical Indicators

Market Signals
Indicator
PAI
NBP
Relative Strength Index (RSI) 43.19 20.60
Support Level $11.24 N/A
Resistance Level $12.35 $1.45
Average True Range (ATR) 0.08 0.07
MACD -0.01 -0.01
Stochastic Oscillator 14.81 9.25

Price Performance

Historical Comparison
PAI
NBP

About PAI Western Asset Investment Grade Income Fund Inc.

Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. Its primary investment objective is to seek a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. To a lesser extent, the fund also invests in privately placed debt securities and in certain equity securities. Capital appreciation is its secondary investment objective. The fund invests a majority of its net assets in fixed income securities that are rated in the Baa or BBB categories or above at the time of purchase by one or more Nationally Recognized Statistical Rating Organizations (NRSROs) or unrated securities of comparable quality at the time of purchase (as determined by the investment adviser).

About NBP NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Share on Social Networks: